Amador Bioscience completed the acquisition of Ann Arbor Pharmacometrics Group (A2PG)
Amador Bioscience, a global translational sciences and clinical pharmacology CRO, announced that it has completed the acquisition of Ann Arbor Pharmacometrics Group (A2PG), a premier…
Read More...
Read More...
